GV 2019 Gp, LLC, 10% Owner at Prime Medicine, Inc. (PRME), sold 95,109 shares at $14.48 ($934K) on 2023-06-09, disclosed to the SEC on 2023-06-13.
Scheduled sale ($934k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,672 | $0 | 0.0% |
| 2 | $14.48 | 15,672 | $227K | 24.3% |
| 3 | $14.48 | 15,672 | $227K | 24.3% |
| 4 | $0.00 | 16,031 | $0 | 0.0% |
| 5 | $14.98 | 16,031 | $240K | 25.7% |
| 6 | $14.98 | 16,031 |
| $240K |
| 25.7% |
| Total | $9.82 avg | 95,109 | $934K | 100% |
| Filing → |
| LIFE | SELL | 2026-07-23 | $1.4M | — | Filing → |
| LIFE | SELL | 2026-07-21 | $730K | — | Filing → |
| LIFE | SELL | 2026-07-17 | $1.8M | — | Filing → |